Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Impact of MK-0518 (Raltegravir) Intensification on HIV-1 Viral Latency in Patients With Previous Complete Viral Suppression

This study has been completed.
Fundacio Lluita Contra la SIDA
Information provided by:
Germans Trias i Pujol Hospital Identifier:
First received: November 5, 2007
Last updated: November 12, 2009
Last verified: November 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2009
  Primary Completion Date: May 2009 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):